Ir para o conteúdo
debya
Português
Entrar Cadastre-se grátis
Ver no Bluesky Acompanhar esta conta

Francesco Bertoni

@frbertoni.bsky.social did:plc:am3g2x2ua4npyujnygdinh32

Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma

No Bluesky desde

Seguidores
130
Seguindo
190
Posts
65
Dias nos rankings
0

Resumo

Francesco Bertoni (@frbertoni.bsky.social) é um usuário do Bluesky desde 15 abril 2025. Tem 130 seguidores, segue 190 contas e publicou 65 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Shannon Buckley, Francesco Bertoni, and Justin Taylor discussed "Degraders in Lymphoma" during a plenary session at the AACR Conference on Advances in Malignant Lymphoma. #AACRlymphoma26 @frbertoni.bsky.social

    Ver post
  • American Association for Cancer Research (AACR)@theaacr.bsky.social

    Degraders in Lymphoma: Shannon Buckley, Francesco Bertoni, and Justin Taylor will address this topic in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/XH3lbfr #AACRlymphoma26 @frbertoni.bsky.social

    Ver post
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews 🌊 Researchers from the IOR and the University of Galway in Ireland have identified a new natural compound from Irish marine life showing strong potential against an aggressive, hard-to-treat form of blood cancer. Learn more: ior.usi.ch/events-news/...

    Ver post
  • International Conference on Malignant Lymphoma@icmlugano.bsky.social

    Yesterday we had our first 19-ICML Local Organising Committee meeting — the behind-the-scenes work for the next edition has officially begun! 💥 @frbertoni.bsky.social #19ICML #ICML #lymphoma #CLL #myeloma #lymssm

    Ver post
  • Institute of Oncology Research (IOR)@iorbellinzona.bsky.social

    #IORnews A collaborative team from IOR, Dana-Farber Cancer Institute (Harvard Medical School), and biotech iOnctura reports that the novel drug roginolisib may boost the effectiveness of venetoclax in blood cancers such as DLBCL, mantle cell lymphoma, and CLL. Learn more: tinyurl.com/ytybcbr8

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.